Antibacterial effect of Manuka honey on Clostridium difficile

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Hammond, Eric N ^a,c   Donkor, Eric S ^b  

^a Global Health Systems Solutions   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; LEPTOSPERMUM; LEPTOSPERMUM SCOPARIUM;

ANTIINFECTIVE AGENT;

DRUG EFFECTS; HONEY; MICROBIAL SENSITIVITY TEST; PEPTOCLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; HONEY; MICROBIAL SENSITIVITY TESTS;

EID: 84877020084     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-188     Document Type: Article

References (34)

1. Clostridium Difficile and the aetiology of Pseudomembranous Colitis. Larson HE, Price AB, Honour P, Borriello SP, Lancet 1978 311 8073 1063 1066 10.1016/S0140-6736(78)90912-1
2. Clostridium difficile-associated disease: new challenges from an established pathogen. Sunenshine RH, McDonald LC, Cleve Clin J Med 2006 73 2 187 197 10.3949/ccjm.73.2.187 16478043
3. Clostridium difficile-more difficult than ever. Kelly CP, LaMont JT, N Engl J Med 2008 359 18 1932 1940 10.1056/NEJMra0707500 18971494
4. Epidemiology of Clostridium difficile-associated infections. Barbut F, Petit JC, Clin Microbiol Infect 2001 7 405 410 10.1046/j.1198-743x.2001.00289.x 11591202
5. Antibiotics and Clostridium difficile. Gorbach SL, N Engl J Med 1999 341 1690 1691 10.1056/NEJM199911253412211 10572160
6. Clostridium difficile-associated diarrhea and colitis. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr, Infect Control Hosp Epidemiol 1995 16 459 477 10.1086/648363 7594392
7. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C. difficile toxins A and B and latex reactive protein. Borriello SP, Barclay FE, Reed PJ, Welch AR, Brown JD, Burdon DW, J Clin Pathol 1987 40 573 580 10.1136/jcp.40.5.573 3108333
8. Antimicrobial resistance in Clostridium difficile. Huang H, Weintraub A, Fang H, Nord CE, Int J Antimicrob Agents 2009 34 6 516 522 10.1016/j. ijantimicag.2009.09.012 19828299
9. Resistance to antibiotics: are we in the post-antibiotic era? Alanis AJ, Arch Med Res 2005 36 697 705 10.1016/j.arcmed.2005.06.009 16216651
10. Epidemiology of resistance to antibiotics. Links between animals and humans. Van de Bogaard AE, Stobberingh EE, Int J Antimicrob Agents 2000 14 327 335 10.1016/S0924-8579(00)00145-X 10794955
11. Minerals in honey: environmental, geographical and botanical aspects. Bogdanov S, Haldimann M, Luginbühl W, Gallmann P, J Apic Res 2007 46 4 269 275
12. Majno G, The Healing Hand. Man and Wound in the Ancient World Cambridge, MA: Harvard University Press 1975 571
13. Why do some cavity wounds treated with honey or sugar paste heal with scarring? Topham J, J Wound Care 2002 11 53 55 11901739
14. Using honey to inhibit wound pathogens. Cooper R, Nurs Times 2008 104 3 46 48-9 19054972
15. The inhibition of biofilms of Pseudomonas aeruginosa with Manuka honey. Cooper RA, Jenkins L, Ostomy Wound Management 2009 54 4 70
16. How honey kills bacteria. Kwakman PH, Te Velde AA, de Boer L, Speijer D, Vandenbroucke-Grauls CM, Zaat SA, FASEB J 2010 24 2576 2582 10.1096/fj.09-150789 20228250
17. Non-peroxide antibacterial activity in some New Zealand honeys. Molan PC, Russell KM, J Apic Res 1988 27 1 62 67
18. Studies on the formation of methylglyoxal from dihydroxyacetone in Manuka (Leptospermum scoparium) honey. Atrott J, Haberlau S, Henle T, Carbohydr Res 2012 361 7 11 22960208
19. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mavric E, Wittmann S, Barth G, Henle T, Mol Nutr Food Res 2008 52 4 483 489 10.1002/mnfr.200700282 18210383
20. Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa. Mukherjee S, Chaki S, Das S, Sen S, Dutta SK, Dastidar SG, Indian J Exp Biol 2011 49 547 551 21800506
21. Inhibitory activity of honey against foodborne pathogens as influenced by the presence of hydrogen peroxide and level of antioxidant power. Taormina PJ, Niemira BA, Beuchat LR, Int J Food Microbiol 2001 69 217 225 10.1016/S0168-1605(01)00505-0 11603859
22. A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of Manuka honey and other honey. Willix DJ, Molan PC, Harfoot CG, J Appl Bacteriol 1992 73 388 394 10.1111/j.1365-2672.1992. tb04993.x 1447054
23. Comparison of the antimicrobial activity of Ulmo honey from Chile and Manuka honey against methicillin-resistant Staphylococcus aureus. Escherichia coli and Pseudomonas aeruginosa. Sherlock O, Dolan A, Athman R, Power A, Gethin G, Cowman S, Humphreys H, BMC Complement Altern Med 2010 10 47 10.1186/1472-6882-10-47 20813024
24. Manuka honey as an effective treatment for chronic pilonidal sinus wounds. Thomas M, Hamdan M, Hailes S, Walker M, J Wound Care 2011 20 11 530 533
25. The post-antibiotic effect of manuka honey on gastrointestinal pathogens. Lin SM, Molan PC, Cursons RT, Int J Antimicrob Agents 2010 36 5 467 468 10.1016/j.ijantimicag.2010.06.046 20724118
26. Baron JE, Peterson LR, Finegold SM, Bailey and Scott Diagnostic Microbiology Maryland Heights: C. V. Mosby Co 9 1994 175 177 98-122
27. European Committee on Antimicrobial Susceptibility Testing, Determination of minimum inhibitory concentration of antibacterial agents by broth dilution: Discussion Document, E. Dis 5.1 Växjö: EUCAST 2003
28. European Committee on Antimicrobial Susceptibility Testing, Disk Diffusion Method for Antimicrobial Susceptibility Testing-Version 1.0 Växjö: EUCAST 2012
29. Determination of minimum inhibitory concentrations. Andrews JM, J Antimicrob Chemother 2001 48 Suppl. 1 5 16 11420333
30. Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. Cooper RA, Molan PC, Harding KG, JRSM 1999 92 283 285
31. The use of honey as an antiseptic in managing Pseudomonas infection. Cooper RA, Molan PC, J Wound Care 1999 8 4 161 164 10455629
32. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. Cooper RA, Halas E, Molan PC, J Burn Care Rehabil 2002 23 6 366 370 10.1097/00004630-200211000-00002 12432313
33. Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. Wilkinson JM, Cavanagh MA, J Med Food 2005 8 1 100 103 10.1089/jmf.2005.8.100 15857217
34. Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques. O'Neill A, Chopra I, Expert Opin Investig Drugs 2004 13 1045 1063 10.1517/13543784.13.8.1045 15268641